Clindamycin, erythromycin, and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pigments with human neutrophils in vitro.
about
Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1 beta.Therapy with macrolides in patients with cystic fibrosis.Efficacy of concomitant administration of clarithromycin and acetylcysteine in bronchiolitis obliterans in seventeen sulfur mustard-exposed patients: An open-label study.
P2860
Clindamycin, erythromycin, and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pigments with human neutrophils in vitro.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Clindamycin, erythromycin, and ...... th human neutrophils in vitro.
@ast
Clindamycin, erythromycin, and ...... th human neutrophils in vitro.
@en
type
label
Clindamycin, erythromycin, and ...... th human neutrophils in vitro.
@ast
Clindamycin, erythromycin, and ...... th human neutrophils in vitro.
@en
prefLabel
Clindamycin, erythromycin, and ...... th human neutrophils in vitro.
@ast
Clindamycin, erythromycin, and ...... th human neutrophils in vitro.
@en
P2093
P2860
P356
P1476
Clindamycin, erythromycin, and ...... th human neutrophils in vitro.
@en
P2093
Anderson R
Koornhof HJ
Saunders J
van Niekerk E
P2860
P304
P356
10.1128/AAC.36.6.1236
P407
P577
1992-06-01T00:00:00Z